from the United States Court of Appeals for the Ninth Circuit
See other cases from the Ninth Circuit.
Reply of petitioner Teva Pharmaceuticals USA, Inc. filed.
Brief of respondents Stephen Wendell, et ux. in opposition filed.
Motion to extend the time to file a response is granted and the time is further extended to and including February 2, 2018.
Motion to extend the time to file a response from January 19, 2018 to February 2, 2018, submitted to The Clerk.
Brief amicus curiae of DRI-The Voice of the Defense Bar filed.
Brief amicus curiae of The Chamber of Commerce of the United States of America filed.
Brief of respondent GlaxoSmithKline LLC in support filed.
Motion to extend the time to file a response is granted and the time is extended to and including January 19, 2018.
Motion to extend the time to file a response from December 20, 2017 to January 19, 2018, submitted to The Clerk.
Petition for a writ of certiorari filed. (Response due December 20, 2017)
Application (17A376) granted by Justice Kennedy extending the time to file until November 20, 2017.
Application (17A376) to extend the time to file a petition for a writ of certiorari from October 19, 2017 to November 20, 2017, submitted to Justice Kennedy.
Teva Pharmaceuticals USA, Inc., Petitioner, represented by William McGinley Jay
GlaxoSmithKline LLC, Respondent, represented by Alan Jay Lazarus
Stephen Wendell, et ux., Respondent, represented by Matthew W.H. Wessler
DRI-The Voice of the Defense Bar, Amicus Curiae, represented by Jerrold Joseph Ganzfried
The Chamber of Commerce of the United States of America, Amicus Curiae, represented by John H. Beisner